Liaquat National Journal of Cancer Care

Liaquat National Hospital and Medical College

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Liaquat National Journal of Cancer Care is an open-access journal published by Liaquat National Hospital and Medical College in Pakistan, publishing in english. It is listed in DOAJ according to the sources read. Declared review time at DOAJ: 20 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Liaquat National Hospital and Medical College
ISSN
2789-0112 · 2789-0120
Country
Pakistan
Languages
english
Access
Open access
Articles in DOAJ
123
Declared review time
20 weeks
Declared peer-review model
double_blind

Index listings

  • DOAJ · 2026-02-16
Indexing
DOAJ
APC
—
Declared review time (DOAJ)
20 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

123

Most recent article

6 months ago

Average review time (journal-declared via DOAJ)

20weeks

Works in OpenAlex

102

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

2

i10-index

0

From OpenAlex open data (CC0).

Editorial & policy7
Added to DOAJ
2026-02-16
Declared plagiarism screening
Declared
Other fees beyond APC
No
Editorial board
Official page ↗
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Peer-review policy
View policy
Identity & continuity2
Alternate titles
LNJCC
Source type
journal
Classification2

Subjects (DOAJ)

Medicine

LCC codes

R

Subject areas

  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • Glioma Diagnosis and Treatment
  • Childhood Cancer Survivors' Quality of Life
  • Palliative Care and End-of-Life Issues
  • Glioma Diagnosis and Treatment
Show all subjects (50)
  • Palliative Care and End-of-Life Issues
  • Childhood Cancer Survivors' Quality of Life
  • Advances in Oncology and Radiotherapy
  • Economic and Financial Impacts of Cancer
  • Economic and Financial Impacts of Cancer
  • Gastric Cancer Management and Outcomes
  • Advances in Oncology and Radiotherapy
  • Gastric Cancer Management and Outcomes
  • Head and Neck Cancer Studies
  • Breast Cancer Treatment Studies
  • Ovarian cancer diagnosis and treatment
  • HER2/EGFR in Cancer Research
  • Gastrointestinal Tumor Research and Treatment
  • Patient Dignity and Privacy
  • Breast Cancer Treatment Studies
  • Patient Dignity and Privacy
  • Cancer Treatment and Pharmacology
  • Gastrointestinal Tumor Research and Treatment
  • HER2/EGFR in Cancer Research
  • Ovarian cancer diagnosis and treatment
  • Head and Neck Cancer Studies
  • Testicular diseases and treatments
  • Adrenal and Paraganglionic Tumors
  • Acute Lymphoblastic Leukemia research
  • Neuroendocrine Tumor Research Advances
  • Colorectal Cancer Screening and Detection
  • Lymphoma Diagnosis and Treatment
  • Cancer survivorship and care
  • Neutropenia and Cancer Infections
  • Radiology practices and education
  • Cancer Treatment and Pharmacology
  • Cancer survivorship and care
  • Oral and Maxillofacial Pathology
  • Ethics in medical practice
  • Acute Lymphoblastic Leukemia research
  • Inflammatory Biomarkers in Disease Prognosis
  • Oral and Maxillofacial Pathology
  • Ethics in medical practice
  • Neuroendocrine Tumor Research Advances
  • Testicular diseases and treatments
  • Adrenal and Paraganglionic Tumors
  • Inflammatory Biomarkers in Disease Prognosis

Keywords (DOAJ)

  • cancer etiology
  • epidemiology
  • cancer treatment and management

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: